TheraRadar
← Back
Data updated: Mar 29, 2026

STEMLINE THERAPEUTICS INC

OncologyImmunologyDermatology
Biotech

STEMLINE THERAPEUTICS INC is a biotechnology company focused on Oncology, Immunology, Dermatology.

2018
Since
1
Drugs
-
Trials
0
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

No recent activity
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 51%
1 drugs Phase 3: 2 Phase 2: 2 Phase 1: 12
Immunology 44%
0 drugs Phase 3: 5 Phase 2: 3
Dermatology 3%
0 drugs Phase 2: 1
Gastroenterology 2%
0 drugs Phase 1: 1

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...